Neurent Medical publishes volume two of The PNN Collective
Physicians discuss device features such as impedance-based energy delivery control, flexible leaflets and posterior treatment coverage for chronic rhinitis patients.
See the latest news and media coverage for Neurent Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device company developing minimally invasive treatments for chronic rhinitis
neuromark.comLast updated
In short: Neurent Medical raised €62.5 million in Series C funding and secured a €25 million growth debt facility.
Physicians discuss device features such as impedance-based energy delivery control, flexible leaflets and posterior treatment coverage for chronic rhinitis patients.
Two 30-minute sessions cover final E/M Modifier-25 changes and rate updates affecting CPT 31242, held November 18 and 24, 2026.
The small, non-randomized feasibility study evaluated impedance-controlled posterior nasal nerve RF ablation for chronic migraine, assessing headache days, responder rate, quality of life and safety.
The issue features ENT peer perspectives on identifying chronic rhinitis treatment candidates, optimizing practice workflows, and building confidence in NEUROMARK treatment.
Neurent Medical also welcomed Kyle Dempsey, Partner at MVM Partners, and Cedric Moreau, Partner at Sofinnova Partners, to its Board of Directors. "Millions of patients...
Neurent Medical has closed an oversubscribed Series C financing round, raising €62.5m ($74m) to expa...
Galway's Neurent Medical just raised a €62.5m Series C round that was oversubscribed to advance its medical solution for chronic rhinitis.
Neurent Medical, a Galway, Ireland based medical technology company focused on chronic inflammatory sinonasal diseases, has closed an oversubscribed €62.5 million ($74 million) Series C...
Track Neurent Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.